InsidersTradesSigma
Explore the detailed record of transactions filed by ANDO GORAN. Director active across 1 company, notably EyePoint Pharmaceuticals, Inc.. Aggregated, 2 filings have been published. History available since 9 February 2022. The latest transaction was disclosed on 9 February 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations